PER percheron therapeutics limited

Ann: Webinar Presentation - Phase IIb study of avicursen, page-46

  1. 4,275 Posts.
    lightbulb Created with Sketch. 2046
    Gassy
    Well that would coincide with their trial
    Did i mention anything about none ambulant

    My point being that the FDA take into consideration MRI

    Which contradicts what we have been told and you yourself said

    This document is from the FDA and confirms what i said MRI is taken into account and i personally believe this data was a huge back up in the Duvyzat trial

    Legs or no legs MRI was the the item of discussion not ambulant none ambulant

    And finally i sincerly hope not
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $71.80K 7.180M

Buyers (Bids)

No. Vol. Price($)
1 4649246 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 2600000 2
View Market Depth
Last trade - 15.21pm 13/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.